Stephen Poor

Company: Novartis AG

Job title: Global Program Clinical Head, Scientific Engagement Lead, Ophthalmology Development

Seminars:

Panel Discussion: Navigating What Design Elements are Needed to Optimize Clinical Trials for Dry AMD? 5:15 pm

Understanding the optimal inclusion and exclusion criteria Considering how the heterogenicity of clinical symptoms, diagnosis and manifestation should impact early and latestage clinical trial planning Assessing the feasibility of having smaller scale clinical trialsRead more

day: Conference Day 1